1. Home
  2. QURE vs LMB Comparison

QURE vs LMB Comparison

Compare QURE & LMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$46.70

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Limbach Holdings Inc.

LMB

Limbach Holdings Inc.

HOLD

Current Price

$79.34

Market Cap

960.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
QURE
LMB
Founded
1998
1901
Country
Netherlands
United States
Employees
248
1400
Industry
Biotechnology: Pharmaceutical Preparations
Engineering & Construction
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
960.5M
IPO Year
2013
2014

Fundamental Metrics

Financial Performance
Metric
QURE
LMB
Price
$46.70
$79.34
Analyst Decision
Buy
Strong Buy
Analyst Count
14
3
Target Price
$45.00
$116.67
AVG Volume (30 Days)
2.0M
254.9K
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
29.67
25.68
EPS
N/A
0.36
Revenue
$13,107,000.00
$646,804,000.00
Revenue This Year
$126.12
$15.96
Revenue Next Year
$200.43
$5.90
P/E Ratio
N/A
$219.83
Revenue Growth
N/A
24.68
52 Week Low
$8.73
$65.08
52 Week High
$71.50
$154.04

Technical Indicators

Market Signals
Indicator
QURE
LMB
Relative Strength Index (RSI) 79.16 49.78
Support Level $21.63 $76.49
Resistance Level $60.70 $85.46
Average True Range (ATR) 2.43 5.18
MACD 1.72 0.31
Stochastic Oscillator 84.49 47.53

Price Performance

Historical Comparison
QURE
LMB

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

About LMB Limbach Holdings Inc.

Limbach Holdings Inc is a building systems solutions firm that designs, delivers, and maintains mechanical (heating, ventilation, and air conditioning), electrical, plumbing, and controls (MEPC) systems. The Company partners with owners and operators of facilities across healthcare, industrial and manufacturing, data centers, life sciences, higher education, and cultural and entertainment markets. It operates through two segments: Owner Direct Relationships (ODR), which generates maximum revenue and includes owner direct projects, maintenance, and service on MEPC systems; and General Contractor Relationships (GCR), which manages new construction or renovation projects involving MEPC systems awarded by general contractors or construction managers.

Share on Social Networks: